1981. Real-World Data on Safety and Effectiveness of Glecaprevir/Pibrentasvir for the Treatment of Patients With Chronic Hepatitis C Virus Infection on Opioid Substitution Therapy: Latest Results from the German Hepatitis C-Registry

BACKGROUND: The coformulated direct-acting antivirals glecaprevir/pibrentasvir (G/P) are approved to treat chronic hepatitis C virus (HCV) genotype 1–6 infection. In clinical trials, G/P demonstrated high efficacy, but real-world data in patients on opioid substitution therapy (OST), a population fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Reimer, Jens, Stoehr, Albrecht, Naumann, Uwe, Teuber, Gerlinde, Zamani, Carsten, Mauss, Stefan, Qurishi, Nazifa, Lohmann, Kristina, Kleine, Henning, Pangerl, Andreas, Christensen, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254652/
http://dx.doi.org/10.1093/ofid/ofy210.1637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254652/
http://dx.doi.org/10.1093/ofid/ofy210.1637

Ejemplares similares